Overview
Paul Radensky will address FDA regulatory intent at a 2-12-18 session, “Regulatory Challenges and Outlook for Molecular Diagnostics,” to be held at the Molecular Medicine Tri-Conference 25th anniversary program during February 2018 in San Francisco.
